Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Dezember 2025 04:07 ET | Quelle: Research and Markets

Gene Editing Collaboration and Licensing Deals Trends Report 2025: Comprehensive Listing of 384 Gene Editing Deals Announced Since 2016

Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "Gene Editing Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
01. Dezember 2025 09:56 ET | Quelle: Research and Markets

Gene Editing Technology Trends and Forecast Report 2025: A $10+ Billion Market by 2030, Driven by Technological Advancements, Personalized Medicine Demand, and Rising Genetic & Chronic Disease Burden

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Gene Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
01. Dezember 2025 07:00 ET | Quelle: Metagenomi, Inc.

Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference

Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
19. November 2025 06:18 ET | Quelle: Cellectis Inc.

Cellectis publie un article dans Nature Communications sur un procédé d’édition génomique non viral efficace pour l’insertion génique dans les cellules souches hématopoïétiques

NEW YORK, 19 nov. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome...
19. November 2025 06:18 ET | Quelle: Cellectis Inc.

Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
17. November 2025 07:07 ET | Quelle: Pluristyx, Inc.

Pluristyx Collaborates with Breakthrough T1D to Make “Immune-Cloaked” and Safety Switch-Enabled Allogeneic Cell Line for Type 1 Diabetes Therapies

Pluristyx and Breakthrough T1D partner to engineer an immune-cloaked, safety-enabled iPSC line to advance universal islet therapies for type 1 diabetes.
10. November 2025 07:25 ET | Quelle: Dyadic International, Inc.

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
03. November 2025 09:20 ET | Quelle: SNS Insider pvt ltd

Cell Line Development Market to Reach USD 12.56 Billion by 2032, Driven by Rising Demand for Biologics, Gene Therapies, and Biopharmaceutical Innovation – SNS Insider

Austin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Cell Line Development Market Size & Growth Analysis According to SNS Insider, the global Cell Line Development Market was valued at USD 5.46 billion in...
30. Oktober 2025 05:23 ET | Quelle: SNS Insider pvt ltd

Cell and Gene Therapy Clinical Trials Market Size to Surpass USD 32.96 Billion by 2032, Driven by Rapid Advancements in Regenerative Medicine and Oncology Therapies – SNS Insider

Austin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cell And Gene Therapy Clinical Trials Market Size & Growth Analysis: According to a report published by SNS Insider, the global Cell and Gene Therapy...
20. Oktober 2025 09:15 ET | Quelle: Research and Markets

Gene Editing Market Guide 2025 | Uncurable Diseases Meet Their Match with CRISPR's Revolutionary Medical Applications

Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "Gene Editing Markets. By Application, Technology, Place, Industry & Product With Executive And Consultant Guides" report has been added to ...

Nächste Seite